Tag Archives: psychedelics

Credit: Florian Brand, CEO ATAI Life Sciences

ATAI Life Sciences: Psychedelic Therapies For Global Markets

 Ira Pastor, ideaXme life sciences ambassador and founder of Bioquark, interviews Florian Brand, Co-founder and Chief Executive Officer of ATAI Life Sciences AG. Ira Pastor comments: On a few recent episodes, we have journeyed into the area of psychedelic therapies, which broadly refers to specific therapeutic practices involving pharmacotherapeutic interventions based on psychedelic drugs. In […]

Dr Dennis McKenna, Founder at Symbio Life Sciences, PBC.

Psychedelic Drugs: Mainstream Medicines of the Future?

Ira Pastor, ideaXme longevity and aging ambassador and founder of Bioquark interviews Dr Dennis McKenna, Founder at Symbio Life Sciences PBC. Dennis McKenna has pursued interdisciplinary research focusing on Amazonian ethnopharmacology and plant hallucinogens for over 30 years. He has investigated the potential of psychedelic drugs to help address human health challenges. Please note, this content […]